Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Codex Health Claims "Proportional" Substantiation "Confusing" - U.S. Draft

This article was originally published in The Tan Sheet

Executive Summary

A substantiation model for health-related claims for food - which would allow different levels of supporting evidence based on the type of claim - is inappropriate, the U.S. delegation to the Codex Committee on Food Labeling says in a draft position paper presented for public comment May 1.

You may also be interested in...



Trans Fatty Acids In Infant Formulas Should Be Limited, U.S. Tells Codex

A U.S. delegation urges Codex Alimentarius to curb the amount of trans fatty acids allowed in infant formula because of safety concerns in a draft position paper on Codex' proposed standards for infant formula.

Trans Fatty Acids In Infant Formulas Should Be Limited, U.S. Tells Codex

A U.S. delegation urges Codex Alimentarius to curb the amount of trans fatty acids allowed in infant formula because of safety concerns in a draft position paper on Codex' proposed standards for infant formula.

Trans Fatty Acids In Infant Formulas Should Be Limited, U.S. Tells Codex

A U.S. delegation urges Codex Alimentarius to curb the amount of trans fatty acids allowed in infant formula because of safety concerns in a draft position paper on Codex' proposed standards for infant formula.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091178

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel